{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:21:39Z","timestamp":1723681299978},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"DOI":"10.7759\/cureus.66885","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T20:55:47Z","timestamp":1723668947000},"source":"Crossref","is-referenced-by-count":0,"title":["Sero-Positive Isolated Ocular Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Taimoor A","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Zeshan","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad A","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheharyar","family":"Zameer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.145987","article-title":"Ocular myasthenia gravis: a review","volume":"62","author":"Nair AG","year":"2014","unstructured":"Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Ocular myasthenia gravis: a review. Indian J Ophthalmol. 2014, 62:985-91. 10.4103\/0301-4738.145987","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1606.1999.00253.x","article-title":"Extraocular muscles: relationship of structure and function to disease","volume":"27","author":"Grigg J","year":"1999","unstructured":"Grigg J. Extraocular muscles: relationship of structure and function to disease. Aust N Z J Ophthalmol. 1999, 27:369-70. 10.1046\/j.1440-1606.1999.00253.x","journal-title":"Aust N Z J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/BF01215447","article-title":"Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects","volume":"84","author":"Sommer N","year":"1993","unstructured":"Sommer N, Melms A, Weller M, Dichgans J. Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol. 1993, 84:309-33. 10.1007\/BF01215447","journal-title":"Doc Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e328310da18","article-title":"Medical treatment options for ocular myasthenia gravis","volume":"19","author":"Antonio-Santos AA","year":"2008","unstructured":"Antonio-Santos AA, Eggenberger ER. Medical treatment options for ocular myasthenia gravis. Curr Opin Ophthalmol. 2008, 19:468-78. 10.1097\/ICU.0b013e328310da18","journal-title":"Curr Opin Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The course of myasthenia gravis and therapies affecting outcome","volume":"505","author":"Grob D","year":"1987","unstructured":"Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci. 1987, 505:472-99. 10.1111\/j.1749-6632.1987.tb51317.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1041458","article-title":"Vertical diplopia","volume":"6","author":"Keane JR","year":"1986","unstructured":"Keane JR. Vertical diplopia. Semin Neurol. 1986, 6:147-54. 10.1055\/s-2008-1041458","journal-title":"Semin Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.11.1663","article-title":"Why are eye muscles frequently involved in myasthenia gravis?","volume":"40","author":"Kaminski HJ","year":"1990","unstructured":"Kaminski HJ, Maas E, Spiegel P, Ruff RL. Why are eye muscles frequently involved in myasthenia gravis?. Neurology. 1990, 40:1663-9. 10.1212\/wnl.40.11.1663","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr AS","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010, 10:46. 10.1186\/1471-2377-10-46","journal-title":"BMC Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips LH 2nd","year":"2003","unstructured":"Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003, 998:407-12. 10.1196\/annals.1254.053","journal-title":"Ann N Y Acad Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S389629","article-title":"Ocular myasthenia gravis: a current overview","volume":"15","author":"Behbehani R","year":"2023","unstructured":"Behbehani R. Ocular myasthenia gravis: a current overview. Eye Brain. 2023, 15:1-13. 10.2147\/EB.S389629","journal-title":"Eye Brain"},{"key":"ref12","article-title":"The sleep test for myasthenia gravis. A safe alternative to Tensilon","volume":"11","author":"Odel JG","year":"1991","unstructured":"Odel JG, Winterkorn JM, Behrens MM. The sleep test for myasthenia gravis. A safe alternative to Tensilon. J Clin Neuroophthalmol. 1991, 11:288-292.","journal-title":"J Clin Neuroophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2018301","article-title":"Treatment of ocular myasthenia gravis","volume":"7","author":"Cornblath WT","year":"2018","unstructured":"Cornblath WT. Treatment of ocular myasthenia gravis. Asia Pac J Ophthalmol (Phila). 2018, 7:257-9. 10.22608\/APO.2018301","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1097\/00041327-200206000-00053","article-title":"Neuro-ophthalmology: section 5, basic and clinical science course","volume":"22","author":"Katz B","year":"2002","unstructured":"Katz B. Neuro-ophthalmology: section 5, basic and clinical science course. J Neuroophthalmol. 2002, 22:147.","journal-title":"J Neuroophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234954-sero-positive-isolated-ocular-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T20:55:52Z","timestamp":1723668952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234954-sero-positive-isolated-ocular-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.66885","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}